Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

allogeneic CAR T cells CT0594CP

A preparation of allogeneic T lymphocytes that have been genetically modified to express chimeric antigen receptors (CARs) specific for as of yet undisclosed tumor-associated antigens (TAAs), with potential immunostimulating and antineoplastic activities. Upon administration, allogeneic CAR T cells CT0594CP specifically targets and binds to tumor cells that express the undisclosed TAAs, resulting in tumor cell lysis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic CAR-T cells CT0594CP
Code name:CT 0594CP
CT-0594CP
CT0594CP
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search